Efficacy & Toxicity of CAR-T Trials and The Echelon-1 Trial Brentuximab Vedotin + AVD or ABVD

Elizabeth Brm, MD - HS Clinical Assistant Professor Chao Comprehensive Cancer Center discusses Efficacy & Toxicity of CAR-T Trials and The Echelon-1 Trial Brentuximab Vedotin + AVD or ABVD at MOASCs... Author: moasc Added: 02/06/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts